Jansen et al., 2018 - Google Patents
Genetic meta-analysis identifies 9 novel loci and functional pathways for Alzheimer's disease riskJansen et al., 2018
View PDF- Document ID
- 536792441107325112
- Author
- Jansen I
- Savage J
- Watanabe K
- Bryois J
- Williams D
- Steinberg S
- Sealock J
- Karlsson I
- Hägg S
- Athanasiu L
- Voyle N
- Proitsi P
- Witoelar A
- Stringer S
- Aarsland D
- Almdahl I
- Andersen F
- Bergh S
- Bettella F
- Bjornsson S
- Brækhus A
- Bråthen G
- de Leeuw C
- Desikan R
- Djurovic S
- Dumitrescu L
- Fladby T
- Homan T
- Jonsson P
- Kiddle S
- Rongve K
- Saltvedt I
- Sando S
- Selbæk G
- Skenne N
- Snaedal J
- Stordal E
- Ulstein I
- Wang Y
- White L
- Hjerling-Leffler J
- Sullivan P
- van der Flier W
- Dobson R
- Davis L
- Stefansson H
- Stefansson K
- Pedersen N
- Ripke S
- Andreassen O
- Posthuma D
- Publication year
- Publication venue
- Biorxiv
External Links
Snippet
Alzheimer's disease (AD) is the most frequent neurodegenerative disease with more than 35 million people affected worldwide, and no curative treatment currently available. AD is highly heritable and recent genome-wide meta-analyses have conclusively identified over 20 …
- 206010001897 Alzheimer's disease 0 title abstract description 191
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jansen et al. | Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk | |
| Jansen et al. | Genetic meta-analysis identifies 9 novel loci and functional pathways for Alzheimer’s disease risk | |
| Mirkovic et al. | Genetic association studies of suicidal behavior: a review of the past 10 years, progress, limitations, and future directions | |
| Hooli et al. | Role of common and rare APP DNA sequence variants in Alzheimer disease | |
| Yonan et al. | A genomewide screen of 345 families for autism-susceptibility loci | |
| Cronin et al. | A genome-wide association study of sporadic ALS in a homogenous Irish population | |
| Zou et al. | Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants | |
| Sklar et al. | Whole-genome association study of bipolar disorder | |
| Krohn et al. | Fine‐mapping of SNCA in rapid eye movement sleep behavior disorder and overt Synucleinopathies | |
| Beecham et al. | Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease | |
| Nurnberger et al. | Genetics of psychiatric disorders | |
| Ridge et al. | Mitochondrial genomic analysis of late onset Alzheimer’s disease reveals protective haplogroups H6A1A/H6A1B: the Cache County Study on Memory in Aging | |
| Mathews et al. | Genome-wide linkage analysis of obsessive-compulsive disorder implicates chromosome 1p36 | |
| Cummings et al. | Genome‐wide association and linkage study in the Amish detects a novel candidate late‐onset Alzheimer disease gene | |
| Weidinger et al. | Association study of mast cell chymase polymorphisms with atopy | |
| Ritchie et al. | Electronic medical records and genomics (eMERGE) network exploration in cataract: several new potential susceptibility loci | |
| Subaran et al. | Novel variants in ZNF34 and other brain‐expressed transcription factors are shared among early‐onset MDD relatives | |
| Cooper et al. | Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment | |
| Wong et al. | Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder | |
| Kang et al. | Direct‐to‐consumer genetic testing in China and its role in GWAS discovery and replication | |
| Li et al. | Novel loci for Alzheimer's disease identified by a genome‐wide association study in Ashkenazi Jews | |
| Marui et al. | The NADH‐ubiquinone oxidoreductase 1 alpha subcomplex 5 (NDUFA5) gene variants are associated with autism | |
| Gunasekaran et al. | Evaluation of recurrent GNPTAB, GNPTG, and NAGPA variants associated with stuttering | |
| Harper et al. | Genome-wide association study of incident dementia in a community-based sample of older subjects | |
| Zhou et al. | GWAS including 82,707 subjects identifies functional coding variant in OPRM1 gene associated with opioid use disorder |